| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8bc77326c9a27d01ae7ca0d2fb18d0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17c6c7da627b7bead7208250127b52c2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 |
| filingDate |
2012-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f9b21d5c1196bdb2eff380e6ee7695c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8985ae8d054b409d8a50d0771f969fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f59c8ad18c6dfff4dcf3afb6666d07f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22f386b1dc99d63b3979b55ddda2be52 |
| publicationDate |
2014-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20140039347-A |
| titleOfInvention |
Peptides having Tumor Selective Permeability and Their Uses |
| abstract |
The present invention relates to a tumor selective permeation functional peptide and a use thereof. More particularly, the present invention relates to a VEGF binding protein transduction (VPTD) peptide having a VEGF selectively binding to heparin in a tumor cell or tumor tissue, domain peptide or an HPTD (Heparin binding protein transduction domain) peptide represented by SEQ ID NO: 2; And a complex in which the drug is bound to the peptide. The tumor-permeable functional peptide and the tumor-permeable functional peptide-drug complex according to the present invention can be used for the accurate diagnosis and therapeutic effect of the cancer which selectively binds and accumulates in tumor cells or tumor tissue, and the peptide or complex to be administered is non- And thus it is possible to minimize the side effects that may occur in the body, which is useful for diagnosis and treatment of cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019035545-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016153185-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022035262-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160115314-A |
| priorityDate |
2012-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |